The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Merus Labs International Inc

TSX: MSL
Delayed quote

$1.08

Today's change+0.01 +0.93%
Updated April 24 4:00 PM EDT. Delayed by at least 15 minutes.
 

Merus Labs International Inc

TSX: MSL
Delayed quote

$1.08

Today's change+0.01 +0.93%
Updated April 24 4:00 PM EDT. Delayed by at least 15 minutes.

Merus Labs International Inc up $0.01

Merus Labs International Inc closed up Monday by $0.01 or 0.93% to $1.08. Although unchanged over the last five days, shares are down 6.90% for the last year to date. This security has underperformed the S&P TSX by 60.82% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.13
Updated April 24 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-14.68%

Although this company's net profit margin is negative, it is above the industry average and implies that Merus Labs International Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.63%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue26302620
Total other revenue--------
Total revenue26302620
Gross profit18191714
Total cost of revenue81196
Total operating expense30272821
Selling / general / administrative9853
Research & development--------
Depreciation / amortization910109
Interest expense (income), net operating--------
Unusual expense (income)0002
Other operating expenses, total--------
Operating income-43-2-1
Interest income (expense), net non-operating-2-3-2-3
Gain (loss) on sale of assets--------
Other--------
Income before tax-60-5-3
Income after tax-60-5-3
Income tax, total0000
Net income-60-5-3
Total adjustments to net income--------
Net income before extra. items-60-5-3
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-60-5-3
Inc. avail. to common incl. extra. items-60-5-3
Diluted net income-60-5-3
Dilution adjustment------0
Diluted weighted average shares117117117107
Diluted EPS excluding extraordinary itemsvalue per share-0.050.00-0.04-0.03
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.050.00-0.04-0.02